These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11942973)

  • 1. Assessing the vascular-stromal coefficient in patients with benign prostatic hyperplasia or prostate cancer using transrectal ultrasonography and power Doppler analysis.
    Dobrowolski Z; Jaszczynski J; Drewniak T; Habrat W
    BJU Int; 2002 Apr; 89(6):601-3. PubMed ID: 11942973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonic power Doppler imaging for prostatic cancer: a preliminary report.
    Okihara K; Kojima M; Naya Y; Iida A; Watanabe M; Watanabe H
    Tohoku J Exp Med; 1997 Aug; 182(4):277-81. PubMed ID: 9352620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular angiographic asymmetry on three-dimensional transrectal power Doppler ultrasonography in patients with organ-confined prostate cancer.
    Dobrowolski ZF; Jaszczynski J; Drewniak T; Habrat W; Kusionowicz J
    BJU Int; 2002 Apr; 89(6):614-5. PubMed ID: 11942976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.
    Berger AP; Deibl M; Leonhartsberger N; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer AE; Bartsch G; Frauscher F
    BJU Int; 2005 Nov; 96(7):1073-8. PubMed ID: 16225531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced transrectal ultrasound for assessing vascularization of hypoechoic BPH nodules in the transition and peripheral zones: comparison with pathological examination.
    Yang JC; Tang J; Li Y; Fei X; Shi H
    Ultrasound Med Biol; 2008 Nov; 34(11):1758-64. PubMed ID: 18524461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound.
    Cho JY; Kim SH; Lee SE
    Eur Urol; 2000 Apr; 37(4):443-8. PubMed ID: 10765075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography.
    Cho JY; Kim SH; Lee SE
    J Ultrasound Med; 1998 May; 17(5):283-7. PubMed ID: 9586699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascularity in transition zone prostate tumors resembles normal prostatic tissue.
    van Niekerk CG; Witjes JA; Barentsz JO; van der Laak JA; Hulsbergen-van de Kaa CA
    Prostate; 2013 Apr; 73(5):467-75. PubMed ID: 22996830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity.
    Arger PH; Malkowicz SB; VanArsdalen KN; Sehgal CM; Holzer A; Schultz SM
    J Ultrasound Med; 2004 May; 23(5):623-30. PubMed ID: 15154528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate zones in three-dimensional transrectal ultrasound.
    Strasser H; Janetschek G; Reissigl A; Bartsch G
    Urology; 1996 Apr; 47(4):485-90. PubMed ID: 8638355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia.
    Hayami S; Ushiyama T; Kurita Y; Kageyama S; Suzuki K; Fujita K
    Prostate; 2002 Oct; 53(2):168-74. PubMed ID: 12242732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascularity in benign prostatic hyperplasia.
    Deering RE; Bigler SA; Brown M; Brawer MK
    Prostate; 1995 Mar; 26(3):111-5. PubMed ID: 7534916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.
    Al-Khalil S; Boothe D; Durdin T; Sunkara S; Watkins P; Yang S; Haynes A; de Riese W
    Int Urol Nephrol; 2016 Jan; 48(1):91-7. PubMed ID: 26590832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color Doppler sonography of the prostate.
    Miller SM; Ackermann R
    Urol Int; 1996; 57(3):158-64. PubMed ID: 8912444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
    Berger AP; Deibl M; Halpern EJ; Lechleitner M; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer A; Bartsch G; Frauscher F
    Diabetologia; 2005 Apr; 48(4):784-9. PubMed ID: 15756540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between prostatic parameters of transrectal ultrasonography and age in patients with benign prostatic hyperplasia].
    Cao NL; Lu QJ; Wang XH; Ni JS; Gu BJ; Hu B
    Zhonghua Nan Ke Xue; 2017 Apr; 23(4):315-318. PubMed ID: 29714415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia.
    Abdelwahab O; El-Barky E; Khalil MM; Kamar A
    Int Braz J Urol; 2012; 38(2):250-5; discussion 255-7. PubMed ID: 22555031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suprapubic versus transrectal ultrasonography in assessing the volume of the prostate and the transition zone in patients with benign prostatic hyperplasia.
    Prassopoulos P; Charoulakis N; Anezinis P; Daskalopoulos G; Cranidis A; Gourtsoyiannis N
    Abdom Imaging; 1996; 21(1):75-7. PubMed ID: 8672981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.